Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2020

16.06.2020 | Editorial

Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?

verfasst von: Samilia Obeng-Gyasi, Bridget Oppong, Electra D. Paskett, Maryam Lustberg

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Coronavirus pandemic has exposed substantial racial and ethnic health and healthcare disparities. Black breast cancer patients face significant disparities in stage of presentation, surgical management, and mortality. The objective of this editorial is to examine the possible implications of the surgical delay imposed by the pandemic on black breast cancer patients.

Methods

The American College of Surgeons, the Society of Surgical Oncology, and the American Society of Breast Surgeons recommendations for surgical delay during the Coronavirus Disease 2019 (COVID-19) were evaluated and discussed.

Results

Guidelines by major surgical organizations on surgical delay for breast cancer patients may inadvertently exacerbate disparities in time to surgery for black breast cancer patients. Our recommendations to better characterize the impact of these guidelines on surgical delay among vulnerable populations include the following: (1) track time from biopsy-proven diagnosis to surgery by race and ethnicity, (2) document patient and institution-related reasons for surgical delay, (3) record patient and disease-related variables/reasons for the selection of breast conservation surgery, mastectomy, and reconstruction by race and ethnicity, and (4) collect data on impactful social determinants of health such as financial reserve, housing conditions, stress, and transportation.

Conclusions

The COVID-19 pandemic may exacerbate delays in time to surgery among black breast cancer patients. Surgeons should incorporate collection of social determinants of health into their clinical practice to better understand the impact of COVID-19 on racial and ethnic disparities in surgical management.
Literatur
1.
Zurück zum Zitat Berry D (2020) Why are so many black people dying from coronavirus?. USA Today, USA Today Berry D (2020) Why are so many black people dying from coronavirus?. USA Today, USA Today
2.
Zurück zum Zitat DeSantis CE, Ma J, Goding Sauer A et al (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67:439–448CrossRef DeSantis CE, Ma J, Goding Sauer A et al (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67:439–448CrossRef
3.
Zurück zum Zitat Hung MC, Ekwueme DU, Rim SH et al (2016) Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health. Cancer Epidemiol 45:112–118CrossRefPubMedPubMedCentral Hung MC, Ekwueme DU, Rim SH et al (2016) Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health. Cancer Epidemiol 45:112–118CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Newman LA (2017) Breast Cancer Disparities: Socioeconomic Factors versus Biology. Ann Surg Oncol 24:2869–2875CrossRefPubMed Newman LA (2017) Breast Cancer Disparities: Socioeconomic Factors versus Biology. Ann Surg Oncol 24:2869–2875CrossRefPubMed
5.
Zurück zum Zitat Linnenbringer E, Gehlert S, Geronimus AT (2017) Black-White Disparities in Breast Cancer Subtype: The Intersection of Socially Patterned Stress and Genetic Expression. AIMS Public Health 4:526–556CrossRefPubMedPubMedCentral Linnenbringer E, Gehlert S, Geronimus AT (2017) Black-White Disparities in Breast Cancer Subtype: The Intersection of Socially Patterned Stress and Genetic Expression. AIMS Public Health 4:526–556CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Fedewa SA, Edge SB, Stewart AK et al (2011) Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved 22:128–141PubMed Fedewa SA, Edge SB, Stewart AK et al (2011) Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved 22:128–141PubMed
8.
Zurück zum Zitat George P, Chandwani S, Gabel M et al (2015) Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt) 24:209–217CrossRef George P, Chandwani S, Gabel M et al (2015) Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt) 24:209–217CrossRef
9.
Zurück zum Zitat Ganz PA (2000) Quality of Life Across the Continuum of Breast Cancer Care. Breast J 6:324–330CrossRefPubMed Ganz PA (2000) Quality of Life Across the Continuum of Breast Cancer Care. Breast J 6:324–330CrossRefPubMed
10.
Zurück zum Zitat Services CfMaM: CMS Releases Recommendations on Adult Elective Surgeries, Non-Essential Medical, Surgical, and Dental Procedures During COVID-19 Response, Centers for Medicare and Medicaid Services, 2020 Services CfMaM: CMS Releases Recommendations on Adult Elective Surgeries, Non-Essential Medical, Surgical, and Dental Procedures During COVID-19 Response, Centers for Medicare and Medicaid Services, 2020
11.
Zurück zum Zitat Oncology. SoS: Resource for Management Options of Breast Cancer During COVID-19, 2020 Oncology. SoS: Resource for Management Options of Breast Cancer During COVID-19, 2020
12.
Zurück zum Zitat Dietz JY, K., Krutzman, s., Anderson B., Willey, S., Boolbol, S., Bleicher, R. Sarantou T., Baron, P. Isakoff, S. Gradishar, W. Burstein, H. Schulman, L., Moran, M., Stevens, R., Lyons, J.: Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic: Executive Summary, 2020 Dietz JY, K., Krutzman, s., Anderson B., Willey, S., Boolbol, S., Bleicher, R. Sarantou T., Baron, P. Isakoff, S. Gradishar, W. Burstein, H. Schulman, L., Moran, M., Stevens, R., Lyons, J.: Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic: Executive Summary, 2020
13.
Zurück zum Zitat O'Brien KM, Cole SR, Tse C-K et al (2010) Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study. Clin Cancer Res 16:6100–6110CrossRefPubMedPubMedCentral O'Brien KM, Cole SR, Tse C-K et al (2010) Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study. Clin Cancer Res 16:6100–6110CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Roberts MC, Wheeler SB, Reeder-Hayes K (2015) Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review. Am J Public Health 105(Suppl 3):e4–e15CrossRefPubMedPubMedCentral Roberts MC, Wheeler SB, Reeder-Hayes K (2015) Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review. Am J Public Health 105(Suppl 3):e4–e15CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Newman LA, Kaljee LM (2017) Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review. JAMA Surg 152:485–493CrossRefPubMed Newman LA, Kaljee LM (2017) Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review. JAMA Surg 152:485–493CrossRefPubMed
16.
Zurück zum Zitat Monticciolo L. Debra PMD, Shulman N. Lawrence, Baron L. Paul, Bleicher J. Richard, Kurtzman H., Scott, Sarantou Terry, Stevens E. Randy, Yao A. Katherine, Boolbol K. Susan, Dietz R., Jill, Smith L. Barbara, Specht C. Michelle, Wiley C. Shawna, Martin Miguel, Anderson: COVID-19 Pandemic Breast Cancer Consortium’s Considerations for Re-entry, 2020 Monticciolo L. Debra PMD, Shulman N. Lawrence, Baron L. Paul, Bleicher J. Richard, Kurtzman H., Scott, Sarantou Terry, Stevens E. Randy, Yao A. Katherine, Boolbol K. Susan, Dietz R., Jill, Smith L. Barbara, Specht C. Michelle, Wiley C. Shawna, Martin Miguel, Anderson: COVID-19 Pandemic Breast Cancer Consortium’s Considerations for Re-entry, 2020
17.
Zurück zum Zitat DeSantis CE, Miller KD, Goding Sauer A, et al: Cancer statistics for African Americans, 2019. CA: A Cancer Journal for Clinicians 69:211–233, 2019 DeSantis CE, Miller KD, Goding Sauer A, et al: Cancer statistics for African Americans, 2019. CA: A Cancer Journal for Clinicians 69:211–233, 2019
18.
Zurück zum Zitat Daly B, Olopade OI (2015) A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin 65:221–238CrossRef Daly B, Olopade OI (2015) A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin 65:221–238CrossRef
19.
Zurück zum Zitat Bernardo BM, Zhang X, Beverly Hery CM et al (2019) The efficacy and cost-effectiveness of patient navigation programs across the cancer continuum: A systematic review. Cancer 125:2747–2761PubMed Bernardo BM, Zhang X, Beverly Hery CM et al (2019) The efficacy and cost-effectiveness of patient navigation programs across the cancer continuum: A systematic review. Cancer 125:2747–2761PubMed
20.
Zurück zum Zitat Krok-Schoen JL, Oliveri JM, Paskett ED: Cancer Care Delivery and Women’s Health: The Role of Patient Navigation. Frontiers in Oncology 6, 2016 Krok-Schoen JL, Oliveri JM, Paskett ED: Cancer Care Delivery and Women’s Health: The Role of Patient Navigation. Frontiers in Oncology 6, 2016
21.
Zurück zum Zitat Company. TAB: Cancer Patient Financial Navigation: Helping Patients Manage Their Costs While Protecting Program Margins., in Deirdre. S (ed): Cancer Patient Financial Navigation, 2014 Company. TAB: Cancer Patient Financial Navigation: Helping Patients Manage Their Costs While Protecting Program Margins., in Deirdre. S (ed): Cancer Patient Financial Navigation, 2014
Metadaten
Titel
Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?
verfasst von
Samilia Obeng-Gyasi
Bridget Oppong
Electra D. Paskett
Maryam Lustberg
Publikationsdatum
16.06.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05740-0

Weitere Artikel der Ausgabe 3/2020

Breast Cancer Research and Treatment 3/2020 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.